BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Nephrol. Sep 25, 2026; 15(3): 120119
Published online Sep 25, 2026. doi: 10.5527/wjn.120119
Table 6 Metabolic abnormalities, n (%)
Abnormality
Total (n = 70)
FTSF (n = 30)
RSF (n = 40)
OR
95%CI
P value
Hypercalciuria27 (38.5)11 (36.6)16 (40.0)1.150.45-2.940.78
Hyperoxaluria21 (30.0)9 (30.0)12 (30.0)1.000.36-2.771.00
Hypocitraturia16 (22.8)7 (23.3)9 (22.5)0.960.31-2.980.94
Low urine volume16 (22.8)7 (23.3)9 (22.5)0.960.31-2.980.94
Hyperuricosuria10 (14.2)4 (13.3)6 (15.0)1.150.29-4.450.84
Hyperphosphatemia11 (15.7)5 (16.7)6 (15.0)0.880.26-2.960.85
Primary hyperparathyroidism8 (11.4)3 (10.0)5 (12.5)1.290.27-6.130.74
No abnormality11 (15.7)7 (23.3)4 (10.0)0.360.10-1.240.12


Write to the Help Desk